Announcements Trials
Browse Landscape

Phase

Phase 2 37Phase NA 25Phase 1 11Phase 1/2 6Phase EARLY_PHASE1 5Phase 4 1Phase 3 1Phase 2/3 1

Status

Unknown 3Recruiting 3Terminated 2Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 1Hodgkin Disease 1

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Completed × Fluorodeoxyglucose F18 × Clear all
NCT00433459 2020-03-26

Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

Martin-Luther-Universität Halle-Wittenberg

Phase 3 Completed
2,134 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡